tocophersolan has been researched along with crizotinib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Correia, IJ; Costa, EC; de Melo-Diogo, D; Gallardo, E; Gaspar, VM; Moreira, AF; Oppolzer, D | 1 |
Lin, X; Wang, H; Wu, Y | 1 |
2 other study(ies) available for tocophersolan and crizotinib
Article | Year |
---|---|
Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crizotinib; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Inhibitory Concentration 50; Micelles; Molecular Structure; Piperazines; Polyethylene Glycols; Purines; Pyrazoles; Pyridines; Sildenafil Citrate; Sulfonamides; Vitamin E | 2014 |
Crizotinib loaded polydopamine-polylactide-TPGS nanoparticles in targeted therapy for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Crizotinib; Humans; Lung Neoplasms; Nanoparticles | 2022 |